ERNA - Eterna Therapeutics Inc.
0.207
-0.001 -0.483%
Share volume: 28,555
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.21
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-12-2025 | |
| Total revenue | 1.000 K | |
| Cost of revenue | 0.000 | |
| Gross profit | 1.000 K | |
| Operating expenses | 2.698 M | |
| Selling general and admin | 1.540 M | |
| Research and development | 1.158 M | |
| Total expenses | 2.698 M | |
| Operating income | -2.697 M | |
| Ebit | -2.072 M | |
| Pretax income | -5.748 M | |
| Income tax | 11.000 K | |
| Net income basic | 0.000 | |
| Net income | -5.759 M | |
